Strides Pharma secures overwhelming approval to launch OneSource, a pivotal CDMO, as it seeks final nod from NCLT for growth.
Strides Pharma Science announced that it has received overwhelming approval from shareholders and secured creditors for the formation of OneSource, a specialty contract development and manufacturing organization (CDMO). This decision comes after meetings facilitated by the National Company Law Tribunal (NCLT). The creation of OneSource will integrate the Oral Technologies business from Strides, Sterile Injectables ...